Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung

Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma

(2012) Markku Miettinen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization

(2012) Jason Hanna et al.   BIOTECHNIQUES

Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells

(2012) Christopher R. Zito et al.   PLoS One

VEGFR-2 expression in human melanoma: Revised assessment

(2011) Kerrington R. Molhoek et al.   INTERNATIONAL JOURNAL OF CANCER

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens

(2011) Natasha Rekhtman et al.   MODERN PATHOLOGY

VEGFR2 Translocates to the Nucleus to Regulate Its Own Transcription

(2011) Inês Domingues et al.   PLoS One

Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy

(2011) J. Yao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antibody validation

(2010) Jennifer Bordeaux et al.   BIOTECHNIQUES

Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers

(2010) N. R. Smith et al.   CLINICAL CANCER RESEARCH

Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells

(2010) Sirin A I Adham et al.   LABORATORY INVESTIGATION

Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens

(2010) F. Grossi et al.   ONCOLOGIST

Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer

(2009) Enrique Carrillo de Santa Pau et al.   CANCER

High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma

(2009) V. K. Anagnostou et al.   CLINICAL CANCER RESEARCH

Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach

(2009) F. Grossi et al.   ONCOLOGIST

High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer

(2008) Sriparna Ghosh et al.   HUMAN PATHOLOGY

Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis

(2008) Ifat Sher et al.   INTERNATIONAL JOURNAL OF CANCER

Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung Adenocarcinoma

(2008) Valsamo K. Anagnostou et al.   JOURNAL OF CLINICAL ONCOLOGY